Lyka Labs

{
  "main_header": {
    "sid": 189121,
    "name": "Lyka Labs",
    "stock_name": "Lyka Labs",
    "full_name": "Lyka Labs Ltd",
    "name_url": "stocks-analysis/lyka-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "49.41",
    "chg": -5.88,
    "chgp": "-10.63%",
    "dir": -1,
    "prev_price": "55.29",
    "mcapval": "191.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 500259,
    "symbol": "LYKALABS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE933A01014",
    "curr_date": "Mar 23",
    "curr_time": "",
    "bse_nse_vol": "3.81 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 23, 2026",
    "traded_date_str": "2026 03 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lyka-labs-189121-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Five Consecutive Losses Push Lyka Labs Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-of-rs5009-amid-market-downturn-3907914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3907914.png",
        "date": "2026-03-23 12:55:13",
        "description": ""
      },
      {
        "title": "Lyka Labs Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3896662",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3896662.png",
        "date": "2026-03-17 11:45:33",
        "description": "Lyka Labs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.51.17 on 17 Mar 2026, marking a significant decline amid persistent underperformance and deteriorating financial metrics."
      },
      {
        "title": "Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.51.45",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-of-rs5145-3893415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3893415.png",
        "date": "2026-03-16 10:11:33",
        "description": "Lyka Labs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.51.45 today, marking a significant decline in its stock price amid ongoing financial and market pressures. This fresh low underscores the stock’s persistent underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.54 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-of-rs54-amid-continued-downtrend-3888420",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3888420.png",
        "date": "2026-03-13 09:42:58",
        "description": "Lyka Labs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.54 today, marking a significant decline amid ongoing market pressures and company-specific headwinds. The stock has underperformed its sector and benchmark indices, reflecting persistent challenges in its financial and technical performance."
      },
      {
        "title": "Lyka Labs Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lyka-labs-ltd-is-rated-strong-sell-3886676",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_mojoScore_3886676.png",
        "date": "2026-03-12 10:10:34",
        "description": "Lyka Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 12 March 2026, providing investors with the latest comprehensive analysis."
      },
      {
        "title": "Lyka Labs Ltd Stock Falls to 52-Week Low of Rs 55 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-of-rs-55-amidst-continued-downtrend-3885019",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3885019.png",
        "date": "2026-03-11 10:40:54",
        "description": "Lyka Labs Ltd’s shares declined to a fresh 52-week low of Rs.55 on 11 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent pressures on the company’s valuation amid subdued financial performance and broader market headwinds."
      },
      {
        "title": "Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.56 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-of-rs56-amid-continued-downtrend-3883040",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3883040.png",
        "date": "2026-03-10 15:35:03",
        "description": "Lyka Labs Ltd’s share price declined to a fresh 52-week low of Rs.56 on 10 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s shares have been under pressure, reflecting a series of financial and market challenges that have weighed on investor sentiment."
      },
      {
        "title": "Lyka Labs Ltd Stock Falls to 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-amid-continued-downtrend-3880604",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3880604.png",
        "date": "2026-03-09 16:00:35",
        "description": "Lyka Labs Ltd’s share price has declined to a fresh 52-week low, closing just 0.7% above its lowest level of Rs 56.6. The stock’s recent performance reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector, with the company’s shares underperforming both the sector and broader market indices."
      },
      {
        "title": "Lyka Labs Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-amidst-continued-downtrend-3865550",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LykaLabsLtd_priceRelatedfactors_3865550.png",
        "date": "2026-03-02 16:00:29",
        "description": "Lyka Labs Ltd has reached a 52-week low, with its share price touching Rs 60.59 on 2 Mar 2026, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock’s recent performance reflects a continuation of a downward trend, with multiple factors contributing to its current valuation."
      }
    ],
    "total": 398,
    "sid": "189121",
    "stock_news_url": "https://www.marketsmojo.com/news/lyka-labs-189121"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Update On The Scheme Of Amalgamation",
      "datetime": "17-Mar-2026",
      "details": "Update on the Scheme of Merger- Approved by NCLT Bench",
      "source": "BSE"
    },
    {
      "caption": "Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Resignation Of Cost Auditors",
      "datetime": "06-Mar-2026",
      "details": "As per letter attached",
      "source": "BSE"
    },
    {
      "caption": "Update On The Scheme Of Amalgamation",
      "datetime": "20-Feb-2026",
      "details": "As per the letter attached",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Five Consecutive Losses Push Lyka Labs Ltd to a New 52-Week Low

2026-03-23 12:55:13

Read full news article

Lyka Labs Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-03-17 11:45:33

Lyka Labs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.51.17 on 17 Mar 2026, marking a significant decline amid persistent underperformance and deteriorating financial metrics.

Read full news article

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.51.45

2026-03-16 10:11:33

Lyka Labs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.51.45 today, marking a significant decline in its stock price amid ongoing financial and market pressures. This fresh low underscores the stock’s persistent underperformance relative to its sector and benchmark indices.

Read full news article

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.54 Amid Continued Downtrend

2026-03-13 09:42:58

Lyka Labs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.54 today, marking a significant decline amid ongoing market pressures and company-specific headwinds. The stock has underperformed its sector and benchmark indices, reflecting persistent challenges in its financial and technical performance.

Read full news article

Lyka Labs Ltd is Rated Strong Sell

2026-03-12 10:10:34

Lyka Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 12 March 2026, providing investors with the latest comprehensive analysis.

Read full news article

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs 55 Amidst Continued Downtrend

2026-03-11 10:40:54

Lyka Labs Ltd’s shares declined to a fresh 52-week low of Rs.55 on 11 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent pressures on the company’s valuation amid subdued financial performance and broader market headwinds.

Read full news article

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.56 Amid Continued Downtrend

2026-03-10 15:35:03

Lyka Labs Ltd’s share price declined to a fresh 52-week low of Rs.56 on 10 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s shares have been under pressure, reflecting a series of financial and market challenges that have weighed on investor sentiment.

Read full news article

Lyka Labs Ltd Stock Falls to 52-Week Low Amid Continued Downtrend

2026-03-09 16:00:35

Lyka Labs Ltd’s share price has declined to a fresh 52-week low, closing just 0.7% above its lowest level of Rs 56.6. The stock’s recent performance reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector, with the company’s shares underperforming both the sector and broader market indices.

Read full news article

Lyka Labs Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend

2026-03-02 16:00:29

Lyka Labs Ltd has reached a 52-week low, with its share price touching Rs 60.59 on 2 Mar 2026, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock’s recent performance reflects a continuation of a downward trend, with multiple factors contributing to its current valuation.

Read full news article

View All News